Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
about
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous NephropathyMembranous nephropathy: from models to manAssociation of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathyAn anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor.Antiphospholipase A₂ receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy.TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathyAntiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathyPhospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathyPrevalence of serum anti M-type phospholipase A2 receptor antibody in primary membranous nephropathy: A single center experienceThe role of complement in membranous nephropathy.Immunohistochemical Analysis of Anti-phospholipase A2 Receptor Antibody on Renal Biopsies: A Single Tertiary Care Center Study.Membranous nephropathy associated with the use of levodopa-carbidopa combination.Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy.A novel Time-resolved Fluoroimmunoassay for the quantitative detection of Antibodies against the Phospholipase A2 Receptor.Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues.Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts.
P2860
Q27023372-FB4F6F6B-FAB6-4685-A9E7-D48CE41FF3BDQ33872569-E3D04FA1-46AC-48A9-A5DA-F9E4017AA6F9Q34008949-0C219DFF-D743-4893-A374-D5ED62D852A7Q34700533-7CDC3AF6-305D-4C58-BC52-8D7AB795AC39Q35165809-1FD2D8DD-DF3F-4F11-BCE5-23657B4AF6A1Q35206224-3FA27575-06C2-4D09-BE0B-632075DCE124Q36280364-5D7A2094-3935-47C3-8310-19FAA7D2A36FQ36719250-C9E0B93B-8A1B-44C4-A91E-044A08C79144Q37135113-CF9A8306-B38B-4FB9-9764-CFD92172B2B0Q38155652-A7973A0F-A1E7-4DA2-92DE-78AA35CC0617Q40042237-9B863930-491D-4EBF-BB76-0F2D4B91E3FFQ41942574-D2D8E863-1E18-40E2-9761-969F1B1000DFQ41964778-CB726BAA-761B-45B5-9401-7FC63C20E8EFQ42292300-1AE2DEB5-6C39-432A-93F1-7F21F11FF85BQ42588842-78302794-5185-479F-8509-4746357E86BEQ42920596-D8C33589-F16F-488B-8D7A-D68FBB7AAE73
P2860
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
@en
type
label
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
@en
prefLabel
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
@en
P1476
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
@en
P2093
Hofstra JM
Wetzels JF
P304
P577
2012-04-01T00:00:00Z